Motion Sickness

Manufacturer
Hyland's Consumer Health Inc.
Effective date
2022-09-08
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
full-release
Hydrated at
2026-06-01 02:18:06

Label at a glance#

ProductMotion Sickness
Active ingredientSTRYCHNOS NUX-VOMICA SEED, TOBACCO LEAF, KEROSENE, ANAMIRTA COCCULUS SEED
Label structure10 sections

Indications and uses

■ Temporarily relieves symptoms associated with motion sickness, including: ■ nausea ■ headache with nausea ■ vomiting ■ dizziness ■ sour stomach

Dosage and administration

■ Use as directed. Adults and children 12 years and over At onset of symptoms, dissolve 2 tablets under tongue every 4 hours until relieved, up to 6 times per day. Children 6 years to under 12 years At onset of symptoms, dissolve 1 tablet under tongue every 4 hours until relieved, up to 6 times per day.

Label contents#

Full prescribing information#

OTC - PURPOSE SECTION

Temporarily relieves symptoms associated with motion sickness, including nausea, headache with nausea, vomiting, dizziness, sour stomach

Drug Facts

SPL UNCLASSIFIED SECTION

OTC - ACTIVE INGREDIENT SECTION

Active IngredientsPurpose
Cocculus Indicus 30X HPUSnausea, dizziness, vomiting

Nux Vomica 6X HPUS

(0.0000016% Alkaloids, calculated)

sour stomach, nausea
Petroleum 12X HPUSnausea, dizziness
Tabacum 6X HPUSheadache with nausea, vomiting

"HPUS" is the Homeopathic Pharmacopoeia of the United States.

Uses

INDICATIONS & USAGE SECTION

■ Temporarily relieves symptoms associated with motion sickness, including: ■ nausea ■ headache with nausea ■ vomiting ■ dizziness ■ sour stomach

Warnings

WARNINGS SECTION

Stop use and ask a doctor if

OTC - STOP USE SECTION

symptoms persist more than 72 hours or worsen.

If pregnant or breastfeeding

OTC - PREGNANCY OR BREAST FEEDING SECTION

Ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Directions

DOSAGE & ADMINISTRATION SECTION

■ Use as directed.

Adults and children
12 years and over
At onset of symptoms, dissolve 2 tablets under tongue
every 4 hours until relieved, up to 6 times per day.
Children 6 years
to under 12 years
At onset of symptoms, dissolve 1 tablet under tongue
every 4 hours until relieved, up to 6 times per day.

Inactive Ingredient

INACTIVE INGREDIENT SECTION

Acacia Gum, Lactose.

Indications and Usage

RECENT MAJOR CHANGES SECTION

 Temporarily relieves symptoms associated with motion sickness, including:
 nausea  headache with nausea  vomiting  dizziness  sour stomach

Dosage and Administration

RECENT MAJOR CHANGES SECTION

Directions ■ Use as directed.

Adults and children
12 years and over
At onset of symptoms, dissolve 2 tablets under tongue
every 4 hours until relieved, up to 6 times per day.
Children 6 years
to under 12 years
At onset of symptoms, dissolve 1 tablet under tongue
every 4 hours until relieved, up to 6 times per day.

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Hyland's

NATURALS™

MOTION

SICKNESS*

NON-DROWSY

• NAUSEA

• VOMITING

• DIZZINESS

50

QUICK-DISSOLVING TABLETS

HOMEOPATHIC

CartonCarton

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
54973-9147-1Motion Sickness50 in 1 BOTTLE, PLASTICTABLET, SOLUBLE504
54973-9147-2Motion Sickness16 in 1 BOTTLE, PLASTICTABLET, SOLUBLE164
54973-9147-2Motion Sickness1 in 1 CARTONTABLET, SOLUBLE14

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
54973-9147MOTION SICKNESS (STRYCHNOS NUX-VOMICA SEED, TOBACCO LEAF, KEROSENE, AND ANAMIRTA COCCULUS SEED) TABLET, SOLUBLE [HYLAND'S CONSUMER HEALTH INC.]4Current NDC, Legacy NDC, 3 package rows20220911_13ba963e-94cb-495b-bd1c-8acf214b6f6e.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
ANAMIRTA COCCULUS SEEDACTIVE INGREDIENT810258W28U1
KEROSENEACTIVE INGREDIENT1C89KKC04E1
STRYCHNOS NUX-VOMICA SEEDACTIVE INGREDIENT269XH139191
TOBACCO LEAFACTIVE INGREDIENT6YR2608RSU1
ANAMIRTA COCCULUS SEEDACTIVE MOIETY810258W28U1
KEROSENEACTIVE MOIETY1C89KKC04E1
STRYCHNOS NUX-VOMICA SEEDACTIVE MOIETY269XH139191
TOBACCO LEAFACTIVE MOIETY6YR2608RSU1
LACTOSEINACTIVE INGREDIENTJ2B2A4N98G1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
54973-914754973-9147-1, 54973-9147-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 54 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
LACTOSELACTOSEJ2B2A4N98GCAPSULE, EXTENDED RELEASE / ORAL120 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GTABLET / ORAL2500 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GTABLET, CHEWABLE / ORAL1412 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GTABLET, DELAYED RELEASE / ORAL160 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GTABLET, EFFERVESCENT / ORAL96.5 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GTABLET, DELAYED RELEASE / ORAL160 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GTABLET, CHEWABLE / ORAL1412 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GSOLUTION / ORAL1682 mg/15mlExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GCAPSULE, DELAYED RELEASE / ORAL231.84 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GTABLET, FILM COATED, EXTENDED RELEASE / ORAL620 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GCAPSULE, EXTENDED RELEASE / ORAL120 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GTABLET, COATED / ORAL332.05 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GCAPSULE, DELAYED RELEASE / ORAL231.84 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GTABLET, FILM COATED / ORAL590 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GCAPSULE, COATED, EXTENDED RELEASE / ORALNAExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GTABLET, SUGAR COATED / ORALNAExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GGRANULE, FOR SUSPENSION / ORAL512.5 mg/5mlExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GTABLET, CHEWABLE / ORAL1412 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GPOWDER, FOR SOLUTION / ORALNAExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GCONCENTRATE / ORALNAExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GTABLET, FILM COATED, EXTENDED RELEASE / ORAL620 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GCAPSULE, DELAYED RELEASE / ORAL231.84 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GTABLET, SUGAR COATED / ORALNAExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GTABLET, SUGAR COATED / ORALNAExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GTABLET, EFFERVESCENT / ORAL96.5 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GCAPSULE / ORAL530 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GTABLET, DELAYED RELEASE / ORAL160 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GTABLET / ORAL2500 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GCAPSULE / ORAL530 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GTABLET, COATED / ORAL332.05 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GTABLET, FILM COATED, EXTENDED RELEASE / ORAL620 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GCONCENTRATE / ORALNAExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GCAPSULE, COATED PELLETS / ORAL135.2 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GCAPSULE, COATED, EXTENDED RELEASE / ORALNAExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GCAPSULE, EXTENDED RELEASE / ORAL120 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GGRANULE, FOR SUSPENSION / ORAL512.5 mg/5mlExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GPOWDER, FOR SOLUTION / ORALNAExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GPOWDER, FOR SOLUTION / ORALNAExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GCAPSULE, COATED PELLETS / ORAL135.2 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GCAPSULE / ORAL530 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GCAPSULE, COATED PELLETS / ORAL135.2 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GCONCENTRATE / ORALNAExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GTABLET / ORAL2500 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GTABLET, EFFERVESCENT / ORAL96.5 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GGRANULE, FOR SUSPENSION / ORAL512.5 mg/5mlExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GTABLET, FILM COATED / ORAL590 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GCAPSULE, COATED, EXTENDED RELEASE / ORALNAExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GTABLET, EXTENDED RELEASE / ORAL400 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GTABLET, FILM COATED / ORAL590 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GTABLET, COATED / ORAL332.05 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GTABLET, EXTENDED RELEASE / ORAL400 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GTABLET, EXTENDED RELEASE / ORAL400 mgExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GSOLUTION / ORAL1682 mg/15mlExact identifier — unii+route
54 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GSOLUTION / ORAL1682 mg/15mlExact identifier — unii+route
54 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Motion SicknessSTRYCHNOS NUX-VOMICA SEED, TOBACCO LEAF, KEROSENE, AND ANAMIRTA COCCULUS SEEDHyland's Consumer Health Inc.13ba963e-94cb-495b-bd1c-8acf214b6f6e2022-09-08WarningsExact identifier
ndc (package): 54973-9147-1
ndc (package): 54973-9147-2
ndc (product): 54973-9147
ndc11 (package): 54973914701
ndc11 (package): 54973914702
spl id: e831b8e5-6f76-bb61-e053-2a95a90a4cc6
spl set id: 13ba963e-94cb-495b-bd1c-8acf214b6f6e

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.